Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Crohn’s Disease at a Turning Point
In this episode, we explore the latest breakthroughs transforming Crohn’s disease management — from whole-food nutritional therapies and advanced microbiome insights to high-accuracy non-invasive monitoring with intestinal ultrasound. We also discuss emerging IL-23 inhibitors, innovative biomarker research, and remarkable case reports that highlight the future of personalized, less invasive care for patients living with Crohn’s disease.
Bibliography
- Aharoni-Frutkoff Y et al. Whole Food Diet vs Exclusive Enteral Nutrition in Mild–Moderate Crohn’s: RCT. Gastroenterology. 2025;169(7):1462-1474.e2. doi:10.1053/j.gastro.2025.06.011.
- Samnani S et al. Accuracy of Noninvasive Biomarkers & Imaging for Postoperative Crohn’s Recurrence. Clin Gastroenterol Hepatol. 2025;23(13):2433-2447.e9. doi:10.1016/j.cgh.2025.03.030.
- Kaneko M, Sakuraba A. IL-23/IL-12 Inhibitors for Moderate–Severe Crohn’s: Systematic Review & Network Meta-analysis. Ann Med. 2025;57(1):2595874. doi:10.1080/07853890.2025.2595874.
- Santos KO et al. Salivary Biomarkers in Crohn’s & UC: Scoping Review. Int J Mol Sci. 2025;26(22):11195. doi:10.3390/ijms262211195.
- Levine J et al. Upadacitinib + Minoxidil for Crohn’s with Alopecia Universalis: Case Report. J Dermatolog Treat. 2025;36(1):2528704. doi:10.1080/09546634.2025.2528704.
- Guo X et al. Gut Microbiota & Epigenetic Inheritance in IBD. Gut Microbes. 2025;17(1):2490207. doi:10.1080/19490976.2025.2490207.
- Nagayama M, Gogokhia L, Longman RS. Precision Microbiota Therapy for IBD. Gut Microbes. 2025;17(1):2489067. doi:10.1080/19490976.2025.2489067.
- Wang X et al. Nursing Case Report: Adolescent Crohn’s Disease. Medicine. 2025;104(48):e46251. doi:10.1097/MD.0000000000046251.
- Hameed M et al. ESR Guidelines for Diagnosis & Treatment Response in Luminal Crohn’s. Eur Radiol. 2025;35(12):7484-7496. doi:10.1007/s00330-025-11620-2.
- Jairath V et al. Integrating Intestinal Ultrasound in Crohn’s Clinical Trials. Inflamm Bowel Dis. 2025;31(12):3429-3442. doi:10.1093/ibd/izaf196.
